oasis 1 oral semaglutide 50 mg obesity nejm 2023 results New in the September 18, 2025, issue of NEJM: Aspirin for PI3K-Altered Localized Colorectal Cancer (ALASCCA phase 3 trial) https://nej.md/4mpKXNp Orforglipron in Early Type 2 Diabetes (ACHIEVE-1 phase 3 trial) https://nej.md/4ngEZ36 Rybelsus for Weight Loss -

Understanding the role of GLP-1 and nutrition can help guide your decisions and ensure youre fueling your body with the right nutrients to support your weight loss journey

In their study, this conjugation method gave an average DAR of 1.6, which was approximately the same number of sialic acid residues introduced per antibody

It can affect whether youre focused, upbeat, and energetic or whether youre laid back, calm, or down

This dossier synthesises available preclinical data on these compounds and sets the methodological framework for rigorous research protocols

ondansetron can cause constipation) For pain : Multimodal pain management including physiotherapy, appropriate analgesia, and psychological approaches For anxiety : Cognitive behavioural therapy (CBT), mindfulness-based interventions, or appropriate pharmacotherapy For sleep : Sleep hygiene education, cognitive behavioural therapy for insomnia (CBT-I) Patients should work collaboratively with their healthcare team to develop an individualised plan that supports both their weight management goals and overall health, recognising that successful treatment requires addressing all factors that may influence outcomes

Research has explored possible effects on neuronal signaling, oxidative stress, seizures, and neuroprotection, but no large human trials have demonstrated reliable improvements in memory, cognition, or neurological performance